2018 Emerging Immunodiagnostic Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers
This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.
The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 145 pages
And Strategic Profiles of Leading Suppliers
Current and Emerging Technologies
Monoclonal and Polyclonal Antibodies
Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
IT and Automation
Dry Chemistry
Biosensors
Robotics
Molecular Diagnostics
a. Detection Technologies
1. Radioactive Methods
2. Non-Isotopic Methods
b. Instrumentation Review
- Abbott LCX
- BeckmanCoulter/Biomek FX
- Becton Dickinson
- Bio-Rad Gene Scope
- Gen-Probe
- Roche Cobas Amplicor
- Tecan LS Series
c. Biochips Genosensor, Microarrays, Labs-on-the-Chips
Chemometrics
Competitive Profiles
- Abbott Laboratories
- AdnaGen/Alere
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio
- Grifols
- Instrumentation Laboratory
- Kyowa Medex
- Matritech
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE
Global Interventional Cardiology Devices Market (2018-2023)
Global Interventional Cardiology Devices Market (2018-2023) market research report available in single user pdf license with Aarkstore Enterprise at USD 2950
View ReportGlobal Corporate Wellness Market (2018-2023)
The global corporate wellness market is forecast to expand at a CAGR of 4.95%, and will reach a value of USD 61.95 Bn by 2023. The Report also Provides highest revenue and market share.
View ReportEmerging Immunodiagnostic Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers, 2019
This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and
View ReportEmerging Immunodiagnostic Tests, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers, 2019
This 320-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or
View ReportFill The Form For Sample Request